Polypoid cervicitis in cystic fibrosis patients receiving oral contraceptives.
D000328:Adult; D001706:Biopsy; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003550:Cystic Fibrosis / Q000150:complications*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects; D009504:Neutrophils; D009640:Norethindrone / Q000009:adverse effects; D011127:Polyps / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D012131:Respiratory Insufficiency / Q000150:complications; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D002575:Uterine Cervicitis / Q000139:chemically induced* / Q000150:complications
D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D008525:Medroxyprogesterone; D009640:Norethindrone